Skip to content

Clinical trials

Phase 4 Atrial Fibrillation trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 4 Country / region: Canada Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20062
20071
20081
20095
20101
20112
20121
20141
20153
20162
20182
20192
20201
20212
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated5
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Population Health Research Institute5
Montreal Heart Institute3
University of Alberta3
Boehringer Ingelheim2
Ottawa Hospital Research Institute2
Sanofi2
Abbott Medical Devices1
Biosense Webster, Inc.1
Biotronik SE & Co. KG1
Biotronik, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation30
Stroke5
Hemorrhage2
Ischemic Stroke2
Atrial Flutter1
Cerebral Hemorrhage1
Critical Illness1
Embolic Stroke1
Embolism1
Emergencies1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.